Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons (Q36986755)
Jump to navigation
Jump to search
scientific article published on June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons |
scientific article published on June 2016 |
Statements
1 reference
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons (English)
1 reference
Richard E Chaisson
1 reference
Timothy R Sterling
1 reference
Nigel A Scott
1 reference
Jose M Miro
1 reference
Alberto La Rosa
1 reference
Rosa Infante
1 reference
Michael P Chen
1 reference
Debra A Benator
1 reference
Fred Gordin
1 reference
Constance A Benson
1 reference
M Elsa Villarino
1 reference
Tuberculosis Trials Consortium, the AIDS Clinical Trials Group for the PREVENT TB Trial (TBTC Study 26ACTG 5259) The investigators of the TB Trials Consortium and the AIDS Clinical Trials Group for the PREVENT TB Trial are listed in the Supplement, item 17
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference